[Observance of antiretroviral treatments: African specificities].
Since the Durban conference in 2000, the initiatives of access to antiretroviral therapy (ART) have expanded in sub-Saharan Africa. It is of high interest to monitor observance to HAART, in a context of increasing ART use, a rapid increase of patients under HAART, and the sociocultural specificities in Africa. In sub-Saharan Africa the concept of disease without cure does not exist and a disease always has or is attributed an external cause. Optimizing observance is a key element for the success of implementation programs for which we recommend a light monitoring to follow-up patients and the use of first line and effective antiretroviral drugs, with a low genetic barrier (efavirenz, nevirapine). The consequences of non-adherence are extremely negative for a patient in Africa, for whom we have few assessment tools and a limited number of ART. Improvement of adherence requires the involvement of all health care actors including traditional healers.
Eholié
S-P
SP
Service des Maladies Infectieuses et Tropicales, BPV 3 CHU Treichville, Abidjan, Côte d'Ivoire. speholie@globeaccess.net
N'dour
C-T
CT
Cissé
M
M
Bissagnéné
E
E
Girard
P-M
PM
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D000349:Africa / Q000453:epidemiology; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D006801:Humans; D016488:Medicine, African Traditional; D012192:Retroviridae Infections / Q000188:drug therapy* / Q000453:epidemiology*
D044966:Anti-Retroviral Agents